Journal article
Relapsing-Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome
Annals of clinical and translational neurology, Vol.13(2), pp.256-269
02/2026
DOI: 10.1002/acn3.70212
PMCID: PMC12883679
PMID: 41051180
Appears in UI Libraries Support Open Access
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurological impairment. While the gut microbiota's role in MS is extensively studied, the association between the oral microbiota and MS remains underexplored, particularly in North American cohorts. This study aimed to investigate the microbiota (bacterial) composition as well as functional pathways and immune profiles of the oral cavity in 60 patients with relapsing-remitting MS (RRMS), stratified by treatment status, compared to 44 healthy controls (HC).
Unstimulated saliva was collected for genomic DNA extraction and salivary cytokine quantification. Oral bacterial composition and diversity were analyzed using 16S rRNA sequencing, with functional pathways inferred using PICRUSt2. Salivary cytokine levels were measured via multiplex immunoassays. LEfSe and random forest models identified key discriminatory taxa, and correlations between microbiota and cytokines were assessed using Spearman's rank analysis.
RRMS patients exhibited distinct microbial communities compared to HC and a higher Bacteroidota to Firmicutes ratio. Key taxa such as Campylobacter, Lachnoanaerobaculum, and Porphyromonas were enriched in RRMS. Functional profiling revealed 49 differentially abundant pathways, including the enrichment of lipopolysaccharide biosynthesis in MS. Elevated levels of IFN-γ, IL-6, and other cytokines correlated with the altered microbiome. IL-21, elevated in HC, correlated with anti-inflammatory pathways, suggesting a protective role in immune homeostasis.
This study provides, for the first time, insights into oral microbiome-host interactions in North American RRMS patients, underscoring the interplay between microbial dysbiosis, functional pathways, and immune dysregulation. The oral microbiome shows potential as a biomarker for MS-related immune alterations.
Details
- Title: Subtitle
- Relapsing-Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome
- Creators
- Sukirth M Ganesan - University of IowaMeeta Yadav - University of IowaSudeep Ghimire - University of IowaPeter C Lehman - University of IowaApurva J Patel - University of IowaSydney Woods - Department of Periodontics, University of Iowa College of Dentistry and Dental Clinics, Iowa City, Iowa, USAHeena Olalde - University of IowaJemmie Hoang - University of IowaMishelle Paullus - University of IowaCatherine Cherwin - University of IowaChristine Gill - University of IowaTracey Cho - University of IowaAshutosh K Mangalam - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Annals of clinical and translational neurology, Vol.13(2), pp.256-269
- DOI
- 10.1002/acn3.70212
- PMID
- 41051180
- PMCID
- PMC12883679
- NLM abbreviation
- Ann Clin Transl Neurol
- ISSN
- 2328-9503
- eISSN
- 2328-9503
- Publisher
- Wiley
- Grant note
- Carver Trust Department of Pathology, University of Iowa 10.13039/100000002 / National Institute of Health, USA 1P20NR018081-01 / NINR NIH HHS University of Iowa Environmental Health Sciences Research Center 5T90DE023520 / NIH HHS 1I01CX002212 / US department of Veterans Affairs 1RO1AI137075 / National Institute of Allergy and Infectious Diseases, USA T32AI007260 / NIH HHS
- Language
- English
- Electronic publication date
- 10/06/2025
- Date published
- 02/2026
- Academic Unit
- Neurology; Pathology; Iowa Neuroscience Institute; Nursing; Medicine Administration; Periodontics
- Record Identifier
- 9984969243602771
Metrics
34 Record Views